Professor
Univ of Washington
Jashvant (Jash) Unadkat, Ph.D. is a Professor in the Dept. of Pharmaceutics at the School of Pharmacy, University of Washington, Seattle. He received his Bachelor’s degree in Pharmacy (B.Pharm.) from the University of London (1977), his Ph.D. from the University of Manchester and his postdoctoral training at the University of California at San Francisco. He held the Milo Gibaldi Endowed Professorship in the Department from 2016-21. Dr. Unadkat’s research interests are on mechanisms of transport and metabolism of drugs during pregnancy, and transport of drugs across the placental, hepatic, intestinal and blood-brain barrier. Dr. Unadkat has published more than 250 peer-reviewed research papers. He is a fellow of AAAS, AAPS, JSSX, and the founding co-chair (1999-2001) of the focus group of AAPS on Drug Transport and Uptake. Dr. Unadkat received the AAPS Research Achievement Award in 2012 and the ISSX Scientific Achievement Award in 2023. Dr. Unadkat created and led the UW Research Affiliates Program on Transporters (UWRAPT), a cooperative effort between the UW School of Pharmacy and pharmaceutical companies, for 10 years. He also leads UWPKDAP, a NIDA funded Program Project grant (P01) on drug disposition during pregnancy. Dr. Unadkat has been an Associate Editor for the Journal of Pharmaceutical Sciences, an Editor of AAPS Journal, and a member of the NIH Pharmacology study section (2000-3). Dr. Unadkat has organized or co-organized numerous national and international conferences on the role of transporters and pregnancy in the disposition of drugs.
http://sop.washington.edu/department-of-pharmaceutics/faculty-members/
https://www.washington.edu/research/research-centers/university-of-washington-research-affiliate-program-on-transporters-uwrapt/
https://sop.washington.edu/department-of-pharmaceutics/research/program-on-pharmacokinetics-of-drugs-of-abuse-during-pregnancy-uwpkdap/
Disclosure information not submitted.
Symposium 1: Clinical Pharmacology of Cannabinoids: Drug Development & Public Health Implications
Sunday, September 8, 2024
10:00 AM – 11:30 AM ET
3 - Cannabinoid Pharmacokinetics in Special Populations: Pregnancy, Pediatrics & Hepatic Impairment
Sunday, September 8, 2024
10:00 AM – 11:30 AM ET